AK-CIDE: SULFACETAMIDE SODIUM,PHENYLEPHRI.
SULFACETAMIDE SODIUM,PHENYLEPHRI. Key specifications include administration: ORAL, features_provided: STERILE, primary_container_type: BOTTLE WITH DROPPER, PLASTIC SQUEEZE, therapeutic_equivalent: NOT RATED, pharmaceutical_vehicle_type: ANY ACCEPTABLE, primary_container_content_quantity: 15.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-913-4577, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| features_provided | STERILE |
| primary_container_type | BOTTLE WITH DROPPER, PLASTIC SQUEEZE |
| therapeutic_equivalent | NOT RATED |
| pharmaceutical_vehicle_type | ANY ACCEPTABLE |
| primary_container_content_quantity | 15.000 MILLILITERS |
| active_medicament_medicinal_strength | 100.000 MILLIGRAMS SULFACETAMIDE SODIUM PER MILLILITER AND 5.000 MILLIGRAMS PREDNISOLONE ACETATE PER MILLILITER |
| NSN | 6505-00-913-4577 |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 10.000 PERCENTAGE, W/V SULFACETAMIDE SODIUM ACTIVE INGREDIENT AND 0.120 PERCENTAGE, W/V PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.200 PERCENTAGE, W/V PREDNISOLONE ACETATE ACTIVE INGREDIENT |